Vir Biotechnology (VIR) hisse fiyatı bugün, piyasa öncesi ve after-hours

Veri

Süpergrafikler

Legend

Daha fazla

Ara

Vir Biotechnology, Inc.

VIR

Nasdaq

Health Technology

Biotechnology

8.80

USD

+0.11

+1.27%

Kapalı: 07-27 20:00 (UTC+0)

8.80

USD

+0.00%

Seans sonrası: 07-28 00:00 (UTC+0)

VIR Temel İstatistikler

YÜKSEK

9.09

Açık

8.82

Hacim

1.68M

Düşük

8.77

Önceki Kapanış

8.69

İşlem Değeri

14.99M

52H En Yüksek

11.66

Göreceli Hacim

1.022

Dalgalanma (%)

3.62%

52H En Düşük

4.16

Devir Oranı

1.00%

Piyasa Değeri

1.46B

F/K (TTM)

F/K (Yıllık)

2.234

GD/DD

1.8

F/S

22.38

Hisse Başına Kazanç (EPS)

-3.137

Temettü (TTM)

Temettü Verimi

0.00%

Dolaşımdaki hisseler

168.65M

Para Birimi

USD

VIR Fiyat Performansı

7 gün

30 gün

90 gün

180 gün

Yıl başından bugüne

1 Yıl

VIR Para Akışı Dağılımı

VIR Günlük Açığa Satış Hacmi

VIR Short Interest Geçmişi

VIR Hisse Özeti

As of 2026-07-28, the Vir Biotechnology, Inc. (VIR) stock price today is 8.8. Based on this price, the company has a market capitalization of $1.46B, with a P/E ratio of --. On 2026-07-28, VIR traded between 8.77 and 9.09. Today’s stock price is 0.34% above the daily low and 3.19% below the daily high, placing VIR alt seviyesine yakın its most recent trading range. Trading volume currently stands at 1.68M, compared with an average daily volume of 1.65M. This suggests that trading activity is olağan seviyesiyle kabaca uyumlu than usual. Over the past year, Vir Biotechnology, Inc. shares have traded between 4.16 and 11.66. At today’s price, VIR is 111.54% above its 52-week low and 24.53% below its 52-week high.

VIR İlgili haberler

Hakkında VIR

Şirket adı

Vir Biotechnology, Inc.

Sektör

Health Technology

Endüstri

Biotechnology

Borsalar

Nasdaq

Çalışan Sayısı

367

Lot Büyüklüğü

100

Resmî web sitesi

www.vir.bio

Para Birimi

USD

Vir Biotechnology Inc is a clinical-stage biopharmaceutical company focused on powering the immune system by discovering and developing medicines for serious infectious diseases and cancer. The company uses its capabilities in antibody discovery and engineering, coupled with its proprietary AI engine dAIsY system, and the PRO-XTEN masking platform, to quickly and effectively discover and optimize potential new medicines. Its clinical development pipeline consists of investigational therapies like Tobevibart + elebsiran targeting the hepatitis delta virus (HDV), preclinical antibody candidates targeting HIV, and VIR-5500, VIR-5818, VIR-5525, and 7 PRO-XTEN programs targeting multiple solid tumors. Currently, the company generates revenue mainly by issuing license rights and through grants.

Related Stocks

VIR FAQ

1.What is the live stock price of Vir Biotechnology, Inc. (VIR) today?

3. What is the latest pre-market price of VIR?

5.How has VIR’s stock price performed recently?

7. What is the current capital flow for VIR?

9. What is the current price of NVDA stock perps?

11. What is the market capitalization of Vir Biotechnology, Inc.?

13. What is Vir Biotechnology, Inc.’s earnings per share (EPS)?

15. Does Vir Biotechnology, Inc. pay dividends?

17. How many employees does Vir Biotechnology, Inc. have?

2. What were VIR’s trading range and trading volume on the most recent trading day?

4.What is VIR’s after-hours price?

6. What are VIR’s 52-week high and 52-week low?

8. What are VIR’s short sale volume and short interest?

10. What are Vir Biotechnology, Inc.’s P/E ratio and valuation metrics?

12. What were Vir Biotechnology, Inc.’s revenue and net income in the most recent quarter?

14.What is Vir Biotechnology, Inc.’s total number of shares outstanding?

16. Which exchange is Vir Biotechnology, Inc. listed on, and what sector and industry does it belong to?

18. What risks should investors consider before investing in VIR?